[go: up one dir, main page]

JPS58224684A - L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria - Google Patents

L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria

Info

Publication number
JPS58224684A
JPS58224684A JP57036901A JP3690182A JPS58224684A JP S58224684 A JPS58224684 A JP S58224684A JP 57036901 A JP57036901 A JP 57036901A JP 3690182 A JP3690182 A JP 3690182A JP S58224684 A JPS58224684 A JP S58224684A
Authority
JP
Japan
Prior art keywords
threonine
strain
lysine
parent strain
brevibacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57036901A
Other languages
Japanese (ja)
Inventor
Masahiko Karasawa
唐沢 昌彦
Osamu Tosaka
戸坂 修
Shigeo Ikeda
茂穂 池田
Hiroi Yoshii
吉井 寛依
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP57036901A priority Critical patent/JPS58224684A/en
Publication of JPS58224684A publication Critical patent/JPS58224684A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To prepare L-threonine, in high efficiency, by culturing L-threonine- producing bacteria belonging to Brevibacterium genus and obtained by cell fusion. CONSTITUTION:An L-threonine-producing bacterial strain requiring L-isoleucine and L-lysine, resistant to alpha-amino-beta-hydroxyvaleric acid and S-(2-aminoethyl) cysteine, belonging to Brevibacterium genus, and obtained by the cell fusion of an L-lysine-requiring strain and S-(2-aminoethyl)cysteine-resistant strain both belonging to Brevibacterium genus, e.g. Brevibacterium lactofermentum AJ 11788 (FERM-P No.6411), is inoculated in a nutrient medium and cultured under aerobic condition at 5-8pH and 29-37 deg.C for 1-4 days. L-threonine is separated from the culture liquid medium.

Description

【発明の詳細な説明】 この発明はL−スレオニン生産菌株及びそれを用いるし
一スレオニンの製造法その前曲方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an L-threonine producing strain and a method for producing l-threonine using the same.

L−スレオニン生産菌株、特Vこブレビバクテリウム属
のし一スレオニン生産4株としては、α−アミノ−β−
ヒドロキシ−吉草酸(以下r AHV Jと記す)に耐
性を有する人工変異株(特公昭45−26708)AH
Vtn耐性を有し、L−1ジン又はL−インロイシン要
求性を有する人工変異株(特公昭48−44876)、
AHVと5−(2−7ミノエチル)−7ステイン(U下
rAEcJと記す)eこ耐性を有しL−1ジンを併産す
る人工変異株(米国特許3732144号)、AHV及
びABCに耐性を有しL−ロイノン要求性を有しし一リ
ジンを併産する人工変異株(特開昭5O−31093)
等が知られている。
L-threonine-producing strains, especially V. The four threonine-producing strains belonging to the genus V.
Artificial mutant strain resistant to hydroxy-valeric acid (hereinafter referred to as rAHV J) (Japanese Patent Publication No. 45-26708) AH
Artificial mutant strain having Vtn resistance and requiring L-1 gin or L-inleucine (Japanese Patent Publication No. 48-44876),
An artificial mutant strain that is resistant to AHV and 5-(2-7minoethyl)-7 stain (rAEcJ) and co-produces L-1 gin (US Pat. No. 3,732,144), which is resistant to AHV and ABC. Artificial mutant strain that has L-leunone auxotrophy and co-produces monolysine (JP-A-5O-31093)
etc. are known.

本発明者らはよりL−スにオニ/生産能が高し・菌株を
得るべく研究した結果、1ついtこブレビ・くクテリウ
ム属のAHVとAECrこ耐性を有し、L−インロイシ
ン及びL−リジン要求性を有する菌株を育種することに
成功し、この菌株が高い収率でL−スレオニアを生産す
ることを知った。
The present inventors conducted research to obtain a strain with higher L-inleucine production ability, and found that it has resistance to AHV and AECr of the genus L-inleucine and L-inleucine. We have succeeded in breeding a strain that has L-lysine auxotrophy, and found that this strain produces L-threonia in high yield.

AHV及びAECtこ剛性を有しし一インロイシン及び
L−’Jリジン要求性有する菌株は、本発明者らの実験
結果にこまれば、ABC耐性とL−リジン要求性を併有
する菌株を人工変異法Pこより得ることができなかった
のて、従って人工変異法により、AHV及びABCに耐
性を有し、し−インロイノン及びL−リジン要求性を有
する菌株を誘導することはできなかった。しかるtこL
−リジン要求性株とABC耐性株とを細胞融合せしめる
ことにより、初めて、L−リジン要求性とABC耐性と
を併有する菌株を得ること?こ成功した。
A strain with AHV and AECt stiffness and an auxotrophy for mono-inleucine and L-'J lysine may be difficult to obtain if the experimental results of the present inventors are taken into consideration. Therefore, it was not possible to induce a strain resistant to AHV and ABC and auxotrophic for inuroinone and L-lysine by artificial mutation. Scolding L
- Obtaining a strain that has both L-lysine auxotrophy and ABC resistance for the first time by cell fusion of a lysine auxotrophic strain and an ABC-resistant strain? This was successful.

本発明のし一スレオニン生産菌を誘導するため1こ細胞
融合に用いる親株の一つ(親株a)は、ブレビバクテリ
ウム属のし一リジン要求性を有し、下記親株b h’−
A HII l111J性及びL−インロイシン要求性
のいずれか一方又゛はその両方の性質を有しない場合t
こけその親株すが有しない性質を有し、5−(2−アミ
ノエチル)−システィン耐性を看しない変異株(具体的
には、          L−jJリジン要求性びA
 )] V剛性株、L−1ジ/要求性、AHV耐性及び
L−イソロイノン要求性株、L−リジン及びLニイソロ
イシン要求性株)であす、他の親株(親株b)は、ブレ
ビバクテリウム属の一一一−AEC耐性を有し、上記親
株aがA HV 剛性及びL−イソロイ7ノ要求性のい
ずれか一方又はその両方の性質を有しない場合にこけそ
の親株aが有しない性質を有し、L−リジン要求性を有
しない変異株(具体的には、AEC耐性株、ABC剛性
及びAHV耐性株、へEC耐性、AHV耐性及びL−イ
ソロイシン要求性株、へEC耐性及びL−イソロイ7ノ
要求性株)である。AHV耐性とL−インロイシン要求
性Pこついては、いずれかの親株がこの性質を有してい
なければならないが、両方の親株がAHV耐性及び/又
はL−インロイシン要求性を有していてもよい。
One of the parent strains (parent strain a) used for cell fusion to induce the threonine-producing bacteria of the present invention has a lysine auxotrophy of the genus Brevibacterium, and the following parent strain b h'-
A HII l111J property and L-inleucine requirement, or if neither of these properties is present.
A mutant strain that has properties that the parent strain of Kokeso does not have and does not have resistance to 5-(2-aminoethyl)-cysteine (specifically, L-jJ lysine auxotroph A)
)] V rigid strain, L-1 di/auxotrophic, AHV resistant and L-isoroinone auxotrophic strain, L-lysine and L-isoleucine auxotrophic strain), and the other parent strain (parent strain b) is Brevibacterium If the above parent strain a does not have the properties of AHV rigidity and/or L-isoloy7 requirement, then the moss has the properties that the parent strain a does not have. and mutant strains that do not have L-lysine auxotrophy (specifically, AEC resistant strains, ABC rigid and AHV resistant strains, EC resistant, AHV resistant and L-isoleucine auxotrophic strains, EC resistant and L-lysine auxotrophic strains, Isoloi 7 auxotrophic strain). AHV resistance and L-inleucine auxotrophy In this case, one of the parent strains must have this property, but even if both parent strains have AHV resistance and/or L-inleucine auxotrophy, good.

これらの変異株の原株は、ブレビバクテリウム属のいわ
ゆるL−グルタミン酸生産菌が好ましい。
The original strain of these mutant strains is preferably a so-called L-glutamic acid producing bacterium belonging to the genus Brevibacterium.

具体的tこ例示すれば以下のものがある。Specific examples include the following.

ブレビバクテリウム・デイバリカタム     ATC
C14(120ブレビバクテリウム・フラバム    
    ATCC13826プレビバクテリウム・ラク
トファーメンタム  ATCC13869ブレビバクテ
リウム・ロゼラム        ATCC13B25
ブレビバクテリウム・チオゲニタリス     ATC
CI 9240親株として使用されるし一すジン要求性
変異株A E C4F耐性 ―■■−−−変異株のいずれも、得られた融合株と区別
するためVこ、栄養要求性等のマーカーとなりうる適当
な性質が更に付学されていてもよい。
Brevibacterium deivaricatam ATC
C14 (120 Brevibacterium flavum
ATCC13826 Previbacterium lactofermentum ATCC13869 Brevibacterium roserum ATCC13B25
Brevibacterium thiogenitalis ATC
The CI 9240 parent strain was used as a auxotrophic mutant strain A.E. C4F resistance - ■■--- All of the mutant strains were used as markers for auxotrophy, etc., to distinguish them from the resulting fusion strain. Further suitable properties may be added.

両親株を融合せしめる方法は、例えばブレビ・4クテリ
ウムIAVこついての融合の例があるAgric、 B
iol、 Chem、、  43. 1007(+97
9)に記載されている方法等の通常の方法が使用できる
。例えば、親株をペニシリンGに暫時接触せしめた後、
高張液中でリゾチームにより細胞壁を除いて親株細胞を
プロトプラストとし、ついで両親株のプロトプラストを
ポリエチレングリコール、ポリビニルアルコール等を含
む高張液中tこて接触せしめて融合せしめる。融合せし
めた後、通常の方法で細胞壁を再生せしめればよい。細
胞壁が再生された菌株よりAHVとΔHCtこ耐性を有
しL−リジンとL−イソロイノン要求性を有する菌株を
選別する方法は全く通常の方法が適用てきる。
The method of merging the parent strains is, for example, Agric, B, which has an example of fusion with Brevi 4cterium IAV.
iol, Chem, 43. 1007 (+97
Conventional methods such as those described in 9) can be used. For example, after exposing the parent strain to penicillin G for a while,
The parent cells are made into protoplasts by removing the cell wall with lysozyme in a hypertonic solution, and then the protoplasts of both parents are brought into contact with a trowel in a hypertonic solution containing polyethylene glycol, polyvinyl alcohol, etc. to fuse. After fusion, the cell wall may be regenerated by a conventional method. A completely conventional method can be used to select a strain having resistance to AHV and ΔHCt and a requirement for L-lysine and L-isoroinone from strains whose cell walls have been regenerated.

得られたし一ヌレオニノ生産菌を培養してL−スレオニ
ンを生産せしめる方法は通常のし一スレオニン生産菌を
培養する方法と特eこ相違する点は栄養素、要1こ必要
によりビタミン、アミノ酸等の有機微量栄養素を含有す
る通常のものが使用できる。炭素源としてはグルコース
、ンコーークーース、フラクトース等の糖類及びこれら
を含有する澱粉分解物、転化糖、モラセス、果汁等が使
用できる。
The method of culturing the obtained mono-threonine-producing bacteria to produce L-threonine differs from the usual method of culturing the mono-threonine-producing bacteria in that it contains nutrients, vitamins, amino acids, etc. as necessary. Ordinary products containing organic micronutrients can be used. As the carbon source, sugars such as glucose, nicococoose, and fructose, starch decomposition products containing these, invert sugar, molasses, fruit juice, etc. can be used.

窒素源としては、アンモニアガス、アノモニア水、アン
モニウム塩等が、無機イオノとして、リン酸イオン、カ
リイオ/、ナトリウ今イオン、鉄イオン、マグネノウム
イオン等が必要1こより適宜培地1こ添加される。
Nitrogen sources include ammonia gas, ammonia water, ammonium salts, etc., and inorganic ions such as phosphate ions, potassium ions, sodium ions, iron ions, and magnenoium ions are added to the medium as appropriate.

培養は、pH5から8の範囲tこ制限しつつ行うのが好
ましく、培養温度を29tl”から37 cノ範囲て行
えば最も好ましい結果が得られる。培養は好気的条件下
で通常1日ないし4日間行なわれる。
Cultivation is preferably carried out while limiting the pH to a range of 5 to 8, and the most favorable results are obtained if the culture temperature is carried out in a range of 29 tl'' to 37 c.Culture is usually carried out under aerobic conditions for 1 day or more. It will be held for 4 days.

かくして培養液中Vこは著昂のL−スレオニンが生成蓄
積される。培養液よりL−スレオーンを採取する方法は
通常の方法でよい。
In this way, a significant amount of L-threonine is produced and accumulated in the culture solution. A conventional method may be used to collect L-threone from the culture solution.

実施例1 ブレビバクテリウム・ラクトフェルメンタムAJ  +
  1786(’FERM−P  ら傷”)(A HV
耐性、ABC耐性、イソロイノン要求性、ロイノン要求
性)およびブレビバクテリウム・ラクトフェルメンタム
AJ11787(FERM−P  gθ10 )(リジ
ン要求性)をペプトン1y/de、酵母エキス197d
e、塩化すl−リウム0.5 f /de及びンユーク
ロースo、5y/deを含み水酸化カリウムでpH7,
2に調節した完全栄養培地(以下”CM培地′″と記す
)を用いて31.5 trにて24時間培養した。
Example 1 Brevibacterium lactofermentum AJ +
1786 ('FERM-P et al.') (A HV
resistance, ABC resistance, isoloinone auxotrophy, leuinone auxotrophy) and Brevibacterium lactofermentum AJ11787 (FERM-P gθ10 ) (lysine auxotrophy) with peptone 1y/de, yeast extract 197d
pH 7 with potassium hydroxide, containing sulfur chloride 0.5 f/de and euculose o, 5y/de.
The cells were cultured for 24 hours at 31.5 tr using a complete nutrient medium (hereinafter referred to as "CM medium") adjusted to 2.

得られた菌体を別々tこlO罰のCM培地を含む大型試
験管に接種し、31..5 rにて振盪培養し対数増殖
中期(I 08cell /me) tこペニノリノG
(31]旧1 /I Ome )を培地に添加した。9
0分間更に培養を続け、培養液から菌体を回収し、これ
を、pH7の高張希釈液(以下rHP液−1と記す、0
.25 Mンユークロース、0.25 Mコノ)り酸2
ナトリウム、100mM00mM塩化カルシュラムM 
リン酸lカリウム、100mM リン酸2カリウム、モ
して5mMEDTA を含みpH7−10,5に調節し
た希釈液)て洗浄した。
31. The obtained bacterial cells were separately inoculated into large test tubes containing CM medium with 100 ml of water. .. Cultured with shaking at 5 r to reach mid-logarithmic growth phase (I 08 cells/me).
(31] old 1 /I Ome ) was added to the medium. 9
Cultivation was continued for 0 minutes, and bacterial cells were collected from the culture solution, which was then diluted with a hypertonic diluted solution (hereinafter referred to as rHP solution-1, pH 7).
.. 25 M euculose, 0.25 M cono)phosphoric acid 2
Sodium, 100mM 00mM Calsulam Chloride M
The plate was washed with a diluted solution containing 1 potassium phosphate, 100 mM dipotassium phosphate, and 5 mM EDTA, adjusted to pH 7-10.5.

表1 最少培地の組成 シュークロース         2.Oy/de硫酸
アンモニウム        0.5  f/de県 
  素                   0.3
   f/deKH,PO40,1f/de MgSO4・7H200,04f /deFeSO4−
7H201,Om9/deMnSO4・4H20+、0
  +I+g/deNaCl            
  10   rng/diMSG         
     10   ■/deL−7ラニン40  1
ng/de ニコチン酸アミ1        5   m97de
アデニ/−101+1g/dム サイアミン塩酸塩      200  /If/lヒ
オチン           I O0711/lpH
7,2(KOH) 菌体を遠心分離し、得られた菌体な5000μy /m
e 、  リゾチーム、0.41 Mシュークロースお
よび0.01 M硫酸マグネシウムを含む最少培地(表
1)に再懸淘し、31.5tl:tこ静置した。プロト
プラストの形成を、光学顕微鏡で観察するとともに、細
胞をHP液で遠心洗浄後、一つはHP液で希釈して0.
5Mコ・・り酸2ナトリウムを含有した最少培地へ接種
し、さらVこo、8y/ae軟寒天を含む同培地て重層
した。もう一つは、リン酸緩衝液で希釈してCM培地1
こ接種し、さらにこo、s y /de軟寒天を含む同
培地−で重層し3I。5Cで培養した。プレート上eこ
出現するコロニーは、各々高張条件で生育するコロニー
(栄養細胞とプロトプラスト)、低張条件で生育するコ
ロニー(栄養細胞のみ)を示し、その実験結果を表21
こ示した。
Table 1 Composition of minimal medium Sucrose 2. Oy/de ammonium sulfate 0.5 f/de prefecture
Elementary 0.3
f/deKH,PO40,1f/de MgSO4・7H200,04f/deFeSO4-
7H201, Om9/deMnSO4・4H20+, 0
+I+g/deNaCl
10 rng/diMSG
10 ■/deL-7 Lanin 40 1
ng/de Amino Nicotinic acid 1 5 m97de
Adeni/-101+1g/d Musaiamine Hydrochloride 200/If/l Hyotine I O0711/lpH
7,2 (KOH) The bacterial cells were centrifuged, and the resulting bacterial cells were 5000μy/m
e, The cells were resuspended in a minimal medium (Table 1) containing lysozyme, 0.41 M sucrose and 0.01 M magnesium sulfate, and allowed to stand for 31.5 tl:t. The formation of protoplasts was observed using an optical microscope, and after centrifugal washing of the cells with HP solution, one was diluted with HP solution to 0%.
The cells were inoculated onto a minimal medium containing 5M disodium cophosphate, and further layered with the same medium containing Vco, 8y/ae soft agar. The other is CM medium 1 diluted with phosphate buffer.
This was inoculated and further layered with the same medium containing soft agar. Cultured at 5C. The colonies that appear on the plate are those that grow under hypertonic conditions (vegetative cells and protoplasts) and those that grow under hypotonic conditions (vegetative cells only), and the experimental results are shown in Table 21.
I showed this.

表     2 2                 9、!Xl08
4.2XI084   5000   1.9XIO”
  7.2XI082.1XIO829,4XIO87
,lXl08 4   1000   3.2X10I′ 8.1XI
081.0Xlo’21              
   2.1XI071.8XI06リゾチ一ム処理2
1時間で、ペニノリン処理細胞はプロトプラスト化され
た□。
Table 2 2 9,! Xl08
4.2XI084 5000 1.9XIO”
7.2XI082.1XIO829, 4XIO87
, lXl08 4 1000 3.2X10I' 8.1XI
081.0Xlo'21
2.1XI071.8XI06 Lysothyme treatment 2
In 1 hour, peninoline-treated cells became protoplasts □.

この処理菌体を33%ポリエチレングリコール(以下r
PEGJと記す)中に懸濁し、36tTで30分間融合
を行なわせた。融合プロトプラストを含むPEG処理液
を遠心分離後、HP液eこ懸濁した。この懸淘液を3o
my/lieリジン、3o、mg/deイア0イン7.
500011?/meA HV、5000μv/rag
 A E Cおよび0.5Mコノ・り酸2ナトリウムを
含んだ高張の最少培地に接種し、0.8%軟寒天を含む
最少培地をその上に重層し、31.5t:で10日間培
養を行なった。高張培地上tこ出現したコロニーを分離
した。
The treated bacterial cells were mixed with 33% polyethylene glycol (hereinafter referred to as r).
PEGJ) and fusion was performed at 36tT for 30 minutes. The PEG-treated solution containing the fused protoplasts was centrifuged and then suspended in HP solution. 3 o of this suspension
my/lie lysine, 3o, mg/deia 0in 7.
500011? /meA HV, 5000μv/rag
The cells were inoculated into a hypertonic minimal medium containing AEC and 0.5 M disodium phosphate, overlaid with a minimal medium containing 0.8% soft agar, and cultured at 31.5 t for 10 days. I did it. Colonies that appeared on the hypertonic medium were isolated.

分離した各コロニーについてスレオニン生産能を調べ、
最も生産能が高いAJ11788(FERM−Pl、(
1// )を分離した。AJ’11788および親株を
L−リジンまたはし一インロイシンを要求性物質として
、生育の度合いを調べた結果を表41こ示した生育度は
、培養24時間後Pこ、26倍希釈液Vこついて562
 nmの吸光度を測定することにより行った。この菌株
は両親株の表現型を有する組換え株で、その表現型は全
く安定であった。
Each isolated colony was examined for threonine production ability,
AJ11788 (FERM-Pl, (
1// ) was separated. Table 41 shows the results of examining the degree of growth of AJ'11788 and the parent strain using L-lysine or inleucine as an auxotroph. 562
This was done by measuring the absorbance at nm. This strain was a recombinant strain that had the phenotype of both parent strains, and its phenotype was completely stable.

表     4 AJ11787 AJ11788 AJ117860m
1glde0    0    0L−Lys    
  30rn’j/de   O,480,0B   
0.09omg/deo     o     。
Table 4 AJ11787 AJ11788 AJ117860m
1glde0 0 0L-Lys
30rn'j/de O,480,0B
0.09omg/deo.

L−Lys+I−lle   各30 mg/de  
O,520,430,080mg/de  0   0
   0 L Lys+L−11e +L−Leu      各30m97de   O,
420,450,5601t?/ral   O,54
、0,460,09※I AHV     5000μm7me   O,100
,410,068、°″′肩 °°“0゛4“ °°゛
L-Lys+I-lle each 30 mg/de
O,520,430,080mg/de 0 0
0 L Lys+L-11e +L-Leu each 30m97de O,
420, 450, 5601t? /ral O,54
, 0,460,09*I AHV 5000μm7me O,100
, 410,068, °"'shoulder °°"0゛4" °°゛.

AEC+Thr   5000pfAll   O,0
70,370,07※I L−リジン、L−インロイノ
ンを各々30my / me含む最少培地tコA HV
 1 またはΔECを添加した。
AEC+Thr 5000pfAll O,0
70,370,07*IL Minimal medium containing 30my/me each of L-lysine and L-inuroinone HV
1 or ΔEC was added.

下記の組成の培地を20me宛、500m1容振盪フラ
スコtこ入れ110Cで10分間蒸気殺菌した。
A medium having the following composition was steam sterilized in a 500 ml shaking flask at 110C for 10 minutes at 20 ml.

これ1こあらかじめCM培地(スランI・)で生育せし
めた表5ンこ示す菌株を一白金耳ずつ接種し31.5 
rtこて72時間振盪培養した。各菌株eこついてのL
−スレオニン蓄積量を表5fこ示す。
One loopful of this was inoculated with the strains shown in Table 5, which had been previously grown on CM medium (Slan I).
Shaking culture was carried out on an rt trowel for 72 hours. Each strain of L
- The amount of accumulated threonine is shown in Table 5f.

培地組成 グルコース          +o   ylde(
NH4)、、So4’       4.5  f/d
(!KH,,PO40,+ 5 f/de MgSO4・7H,00,04f /deFeSO4・
7H201’m’j/、deMnSO4j 4H201
mg/de サイアミン・塩酸塩    +000   Itグ/l
ビオチア           100  1if/1
大豆蛋白塩酸加水分解液       1.0  me
/de消泡剤       20  ■/de炭酸カル
シウム(別殺菌)      5  り/depH7,
2(KOHで中和) 表     5 実施例2 ブレビバクテリウム・フラバムAJ3419(FERM
−PI70B)(八EC”+Ile  ’)およびブレ
ビバクテリウム・フラバムBL−4(微工仙−菌寄第2
]】号)(A’HVr、Lys  )を用いて、実施例
1と同様の方法でプロトプラスト化および融合を行なっ
た。30mg/deL−リジン1、′・ 1 を含む表1の組成の最少培地」二に生育したコロニーA
J I I s I 2 (FERM−P  6(J−
1≠ )を分離し、この菌株の性質tこついて調べた。
Medium composition Glucose + o ylde (
NH4),,So4' 4.5 f/d
(!KH,,PO40,+5 f/de MgSO4・7H,00,04f/deFeSO4・
7H201'm'j/, deMnSO4j 4H201
mg/de Thiamine hydrochloride +000 Itg/l
Biotia 100 1if/1
Soybean protein hydrochloric acid hydrolyzate 1.0 me
/de antifoaming agent 20 ■/de calcium carbonate (separate sterilization) 5 ri/depH7,
2 (neutralized with KOH) Table 5 Example 2 Brevibacterium flavum AJ3419 (FERM
- PI70B) (8 EC"+Ile') and Brevibacterium flavum BL-4 (Weitechsen-B.
]] (A'HVr, Lys), protoplast formation and fusion were performed in the same manner as in Example 1. Colony A grown on minimal medium with the composition shown in Table 1 containing 30 mg/deL-lysine 1,'.
J I Is I 2 (FERM-P 6 (J-
1≠) was isolated and the properties of this strain were investigated.

AJI+812および親株をし一すジ/またはL−イン
ロイシンを要求物質として生育を調べ、さら1こAHV
、AECの薬剤を添加して耐性塵を調べた結果を表6V
こ示した。生育度の測定は実施例1tこ示した方法と同
じである。この菌株は両親株の表現型を有する組換え株
で、その表現型は全く安定てあった。
AJI+812 and the parent strain were examined for growth using di/or L-inleucine as a required substance, and one AHV
Table 6V shows the results of investigating dust resistance by adding AEC chemicals.
I showed this. The determination of the degree of growth was the same as that described in Example 1t. This strain was a recombinant strain that had the phenotype of both parent strains, and its phenotype was completely stable.

表     6 01ny/de   0    0    00mg/
de   OO0 0mg1de   O(l     001n/me 
 ’ 0.45  0,42  0.39※1 ※I   L−リジ/、L−インロイノンを各々30m
g/ de含む最少培地r、: A HVまたはABC
を添加した。
Table 6 01ny/de 0 0 00mg/
de OO0 0mg1de O(l 001n/me
'0.45 0.42 0.39*1 *I 30m each of L-Rigi/ and L-Inroinone
Minimal medium containing g/de: A HV or ABC
was added.

下記の組成の培地を20m1宛、500m1容振盪7う
7コtこ入れI IOrで10分間蒸気殺菌したこれ1
こあらかじめCM培地(スラント)で生育せしめた表7
9こ示す菌株を一白金耳ずつ接種し3 +、5 rにて
72時間振盪培養した。結果を表7に示す。
Add 20 ml of culture medium with the following composition, shake 500 ml, and add 7 pots. Steam sterilize with IOr for 10 minutes.
Table 7 grown in CM medium (slant) in advance
A loopful of each of the following 9 strains was inoculated and cultured with shaking at 3 + and 5 r for 72 hours. The results are shown in Table 7.

培地組成 りルコース          +o   y/rte
(NH< )2 SO<           4.5
  f /diKH2P0.            
0.15 t/deMgS04−7H200,04f 
/deFeSO,・7H,01mg/de MnSO4’4H20+   mg/deサイアミン・
塩酸塩   1000  1t?/1ビオチ:/   
       +00   lif/を大豆蛋白塩酸加
水分解液    1.0  me/de消泡剤    
   20  mg/rye炭酸力ルンウム(別殺菌)
5   y/1tepH7,2(KOHて中和) 表     7 AJ   3419            0A  
、l  I  1 8 1 2          1
7.6B L −49,8 特許出願人 味の素株式会社 手続補正8(方式) %式% 1、事件の表示 昭和57年特W[願第36901号 2、光間の名称 1、−スレAニンノ1産fii’iそれを用いる1−−
スレオニンの製造法及びイの育種方法 3、補正をする者 事1′1どの関係  特許出願人 41所   東京都中央区京橋−丁目5番8号6、補正
の内容  明l1ll書の発明の名称[L−スレオニン
生産菌株それを用いる1−−スレオニンの製造法及びそ
の育種方法]を11−−ス1ノAニン生産菌それを用い
る1〜−スレA二ンの製造法及びその育種方法」と訂正
づる。
Medium composition Lucose +o y/rte
(NH< )2 SO< 4.5
f/diKH2P0.
0.15t/deMgS04-7H200,04f
/deFeSO,・7H,01mg/de MnSO4'4H20+ mg/dethiamine・
Hydrochloride 1000 1t? /1 biochi:/
+00 lif/Soybean Protein Hydrochloric Acid Hydrolyzed Solution 1.0 me/de Antifoaming Agent
20 mg/rye carbonic acid power runium (separate sterilization)
5y/1tepH7,2 (neutralized with KOH) Table 7 AJ 3419 0A
, l I 1 8 1 2 1
7.6B L -49,8 Patent Applicant Ajinomoto Co., Ltd. Procedural Amendment 8 (Method) % Formula % 1, Display of the case 1982 Special W [Application No. 36901 2, Name of Mitsuma 1, - Thread A Ninno 1 production fii'i using it 1--
Threonine production method and A breeding method 3. Person making the amendment 1'1 Relationship Patent applicant 41 5-8-6 Kyobashi-chome, Chuo-ku, Tokyo Contents of the amendment Name of the invention in the book 11ll [ L-threonine-producing strain (method for producing 1-threonine using the same and breeding method thereof); Correction zuru.

Claims (1)

【特許請求の範囲】 1、 ブレビバクテリウム属のα−アミノ−β−ヒI’
Rキシ吉草酸及ヒS −(2−アミノエチル) −シフ
、 ティン1こ耐性を有しL−イソロイシン及びL−リ
ジン要求性を有するし一スレオニ/生産菌株。 2 ブレビバクテリウム属のα−アミノ−β−ヒドロキ
シ吉草酸及び5−(2−アミノエチル) −シy、 テ
ィンに耐性を有しL−インロイジノ及びし−リジン要求
性を有する【−一スレオニン生産菌株を培養し、培養液
中に生成蓄積されたし一スレオニンを採取することを特
徴とするし一スレオニンの製造法。 3 ブレビバクテリウム属のし一すジン要求性ヲ有し、
下記親株すがα−アミノ−β−ヒトロキ・/吉草酸耐性
及びし−イソロイシン要求性のいずれか一方又はその両
方の性質を有しない場合にはその親株すが有しない性質
を有し、5−(2−アミノエチル)−システィン耐性を
有しない親株aのプロトプラスト化した細胞と、ブレビ
バクテリウム属の5−(2−アミノエチル)−システィ
ン耐性を有し、上記親株すがα−アミノ−B−ヒドロキ
ン吉草酸及びL−イソロイシン要求性のいずれか一方又
はその両方の性質を有しない場合にはその親株aが有し
ない性質を有し、L−1+レン要求性を有しない親株す
のプロトプラスト化した細胞とを融合せしめ、α−アミ
ノ−β−ヒドロキシ吉草酸及び5−(2−アミノエチル
)−ンステイ/に耐性を有L、L−170イシ/及びL
−リジン要求性を有するし一
[Claims] 1. α-amino-β-hi I' of the genus Brevibacterium
A 1-threoni/producer strain having resistance to R-xyvaleric acid and S-(2-aminoethyl)-Schiff, and auxotrophy for L-isoleucine and L-lysine. 2 Brevibacterium species that are resistant to α-amino-β-hydroxyvaleric acid and 5-(2-aminoethyl)-cy,tin, and have L-inloidino and di-lysine requirements [-threonine production 1. A method for producing 1-threonine, which comprises culturing a bacterial strain and collecting 1-threonine produced and accumulated in the culture solution. 3. Has a sulfur-requiring property of the genus Brevibacterium,
If the following parent strain does not have the properties of α-amino-β-hydroxy-valeric acid resistance and -isoleucine requirement, or both, it has the properties that the parent strain does not have, and 5- (2-aminoethyl)-cysteine-resistant parent strain a, and the parent strain Suga, which has Brevibacterium resistance to 5-(2-aminoethyl)-cysteine, α-amino-B. - If the parent strain a does not have either or both of hydroquine valeric acid and L-isoleucine requirements, the parent strain a has the characteristics that the parent strain does not have, and the parent strain does not have the L-1+ ren requirement. L, L-170 and L which are resistant to α-amino-β-hydroxyvaleric acid and 5-(2-aminoethyl)-instein/
-Has lysine requirement
JP57036901A 1982-03-09 1982-03-09 L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria Pending JPS58224684A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57036901A JPS58224684A (en) 1982-03-09 1982-03-09 L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57036901A JPS58224684A (en) 1982-03-09 1982-03-09 L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria

Publications (1)

Publication Number Publication Date
JPS58224684A true JPS58224684A (en) 1983-12-27

Family

ID=12482677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57036901A Pending JPS58224684A (en) 1982-03-09 1982-03-09 L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria

Country Status (1)

Country Link
JP (1) JPS58224684A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264353A (en) * 1985-08-23 1993-11-23 Toray Industries, Inc. Process for producing L-threonine by fermentation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264353A (en) * 1985-08-23 1993-11-23 Toray Industries, Inc. Process for producing L-threonine by fermentation

Similar Documents

Publication Publication Date Title
US7052884B2 (en) L-arginine producing Escherichia coli and method of producing L-arginine
DE60129877T2 (en) Amino acid-producing Escherichia strains and process for producing an amino acid
NAKAYAMA et al. Studies on lysine fermentation I. The control mechanism on lysine accumulation by homoserine and threonine
EP0530803B1 (en) Process for producing L-threonine
US4347318A (en) Method for producing L-threonine by fermentation
KR900004425B1 (en) Method for preparing L-arginine
US5521074A (en) Process for producing L-valine
FR2511035A1 (en) PROCESS FOR THE PRODUCTION OF L-LYSINE BY FERMENTATION
JP3717970B2 (en) Method for producing L-isoleucine by fermentation
JPS58152485A (en) Breeding method of microorganism
JP2578492B2 (en) Method for producing L-threonine by fermentation method
JPS58224684A (en) L-threonine-producing bacteria, preparation of l-threonine using the same, and cultivation of said bacteria
US4623623A (en) Process for producing L-lysine by fermentation
JPH0515434B2 (en)
JPS589692A (en) Production of l-arginine through fermentation process
JPH02283290A (en) Production of l-ornithine by fermentation method
JP2971089B2 (en) Method for producing L-threonine by fermentation
JPS59113894A (en) Preparation of l-glutamic acid by fermentation
JPH01187093A (en) Production l-threonine by fermentation method
JPS58224694A (en) L-threonine-producing bacteria, preparation of l-threonine using the same and cultivation of said bacteria
HU215248B (en) Process for producing l-lysine
JPS60241885A (en) Novel variant strain
JPS58220691A (en) Production of l-leucine by fermentation
KR100187607B1 (en) Process for producing l-lysine by fermentation employing a microorganism resistant to acyl-lysine or methylated acyl
JPS58158184A (en) Fusion of protoplast of bacterium